News summary

Science Corporation’s brain tech is worth $3.5 billion after new funding

Source: TechCrunch • Published: 17 Nov 2026, 14:26

Summarized by Masters of Longevity from TechCrunch.

Startup raised $400 million and will expand trials of its PRIMA device.

Science Corporation’s brain tech is worth $3.5 billion after new funding
Key Takeaways
  • Science Corporation raised $400 million in a Series D.
  • PRIMA is approved in Europe and used in Germany.
  • US use via FDA Humanitarian Device Exemption is planned.
Read the full article at TechCrunch ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.